Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 950-955

  Licata, Lisa ^a   Smith, Charles E ^a   Goldschmidt, Raúl M ^a   Barrett, John F ^a   Frosco, Marybeth ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; METICILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG EXPOSURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030955046     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.950     Document Type: Article

References (27)

1. Altemeier, W. A. 1948. Penicillin therapy with prolonged interval dosage schedules. Ann. Surg. 128:708-713.
2. Cars, O., and I. Odenholt-Tornqvist. 1993. The post-antibiotic sub-MIC effect in vitro and in vivo. J. Antimicrob. Chemother. 31(Suppl. D):159-166.
3. Craig, W. A., and S. Gudmundsson. 1991. The postantibiotic effect, p. 403-431. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, Md.
4. Fu, K. P., B. Foleno, and M. Rosenthale. 1992. The post-antibiotic suppressive effect of l-ofloxacin, an optically active isomer of ofloxacin. Diagn. Microbiol. Infect. Dis. 15:375-378.
5. Fu, K. P., S. C. Lafredo, B. Foleno, D. M. Isaacson, J. F. Barrett, A. J. Tobia, and M. E. Rosenthale. 1992. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob. Agents Chemother. 36:860-866.
6. Gottfredsson, M., H. Erlendsdottir, A. Gudmundsson, and S. Gudmundsson. 1995. Different patterns of bacterial DNA synthesis during postantibiotic effect. Antimicrob. Agents Chemother. 39:1314-1319.
7. Houston, A. K., and R. N. Jones. 1994. Postantibiotic effect of DU-6859a and levofloxacin as compared with ciprofloxacin. Diagn. Microbiol. Infect. Dis. 18:57-59.
8. Howard, B. M., R. J. Pinney, and J. T. Smith. 9193. Contributions of postantibiotic lag and repair-recovery to the post-antibiotic effects of ciprofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyogenes. Chemotherapy (Basel) 39:22-31.
9. Howard, B. M., R. J. Pinney, and J. T. Smith. 1993. Post-antibiotic effects of ofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pyogenes. Chemotherapy (Basel) 39:265-271.
10. Kunin, C. M. 1981. Dosage schedules of antimicrobial agents: a historical view. Rev. Infect. Dis. 3:4-11.
11. Kuursted, K. 1987. Post-antibiotic effect of ciprofloxacin on Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. 6:271-274.
12. Lorian, V. 1975. Effects of subinhibitory concentrations of antibiotics on bacteria. Bull. N. Y. Acad. Med. 51:1046-1055.
13. MacKenzie, F. M., and I. M. Gould. 1993. The post-antibiotic effect. J. Antimicrob. Chemother. 32:519-537.
14. McGrath, B. J., C. R. Marchbanks, D. Gilbert, and M. N. Dudley. 1993. In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin. Antimicrob. Agents Chemother. 37:1723-1725.
15. Meng, X., C. H. Nightingale, K. R. Sweeney, and R. Quintiliani. 1994. Loss of bactericidal activities of quinolones during the post-antibiotic effect induced by rifampicin. J. Antimicrob. Chemother. 33:721-728.
16. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard. NCCLS document no. M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. Odelholt, I. 1993. Studies of the post-antibiotic effect and the post-antibiotic sub-MIC effect of meropenem. J. Antimicrob. Chemother. 31:881-892.
18. Odenholt, I., S. E. Holm, and O. Cars. 1989. Effects of henzylpenicillin on Streptococcus pyogenes during post-antibiotic phase in vitro. J. Antimicrob. Chemother. 24:147-156.
19. Odenholt, I., E. Lowdin, and O. Cars. 1991. Pharmacodynamic effect of subinhibitory concentrations of β-lactam antibiotics in vitro. Antimicrob. Agents Chemother. 35:1834-1839.
20. Odenholt-Tornqvist, I., and S. Bengtsson. 1994. Postantibiotic effect and postantibiotic effect of subinhibitory concentrations of sparfloxacin on gramnegative bacteria. Chemotherapy (Basel) 40:30-36.
21. Odenholt-Tornqvist, I., E. Lowdin, and O. Cars. 1992. Postantibiotic subMIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob. Agents Chemother. 36:1852-1858.
22. Oshida, T., T. Onta, N. Nakanishi, T. Matsushita, and T. Yamaguchi. 1990. Activity of sub-minimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus. J. Antimicrob. Chemother. 26:29-38.
23. Oshida, T., K. Shibata, T. Matsushita, M. Ohashi, and T. Yamaguchi. 1994. Post-antibiotic sub-MIC effects of aspoxicillin and other antibiotics. Chemotherapy (Tokyo) 42:1095-1102.
24. Pastor, A., J. Peman, and E. Canton. 1994. In vitro postantibiotic effect of sparfloxacin and ciprofloxacin against Pseudomonas aeruginosa and Enterococcus faecalis. J. Antimicrob. Chemother. 34:679-685.
25. Tsui, S. Y., W. W. Yew, M. S. Li, C. Y. Chan, and A. F. Cheng. 1993. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum. Antimicrob. Agents Chemother. 37:1001-1003.
26. Visalli, M. A., M. R. Jacobs, and P. C. Appelbaum. 1996. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:362-366.
27. Zhanel, G. G., and W. A. Craig. 1994. Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides. Clin. Pharmacokinet. 27: 377-392.